Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sequent Scientific has informed that the company has, as part of its investor’s engagement activities, scheduled a conference call with the Analysts / Investors on Friday, February 01, 2019 to discuss its Q3FY19 financial results.
The above information is a part of company’s filings submitted to BSE.